Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
Celgene
Celgene
Lyell Immunopharma, Inc.
Instituto de Investigación Biomédica de Salamanca
AVM Biotechnology Inc
New York Medical College
BeOne Medicines
Verismo Therapeutics
Mayo Clinic
National Cancer Institute (NCI)
Janssen Research & Development, LLC
AstraZeneca
Beijing Biotech
National University Hospital, Singapore
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center
British Columbia Cancer Agency
AstraZeneca
Shenzhen University General Hospital
Eli Lilly and Company
Suzhou Immunofoco Biotechnology Co., Ltd
Medical University of South Carolina
MSD R&D (China) Co., Ltd.
BeOne Medicines